Enhance Precision Oncology Trial Success

June 4, 2018

A convergence of biological data and computing power is yielding amazing technological progress in clinical research and development. Vast amounts of data, often from disparate sources, are enabling the transformation of treatment paradigms. In many therapeutic areas, with oncology chief among them, traditional broad-spectrum therapies that produce variable or unsatisfactory outcomes in large populations are being supplanted by precision medicines that produce improved patient outcomes in targeted populations.

Spotlight

Neem Biotech Limited

Neem Biotech is an established and now rapidly growing Wales-based biotechnology R&D company. Like Zaluvida, our parent company, we dare to dream big within our areas of expertise in the life sciences in order to pioneer health innovations that go some way to making the world a little better.

OTHER WHITEPAPERS
news image

Next-Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies.

whitePaper | August 19, 2022

The quality of procedures and products used for preparing, transporting and storing cells at cryogenic temperatures have a direct impact on post-thaw viability and functionality, as well as the consistency and reliability of biological agents from a Quality perspective.

Read More
news image

Multi-Attribute Methods for Biopharmaceutical Analysis

whitePaper | December 5, 2022

The adoption of LC-MS-based multi-attribute method (MAM) analysis for routine monitoring of biotherapeutic variation has progressed greatly over the last five years.

Read More
news image

BIOTECHNOLOGY INNOVATION ORGANIZATION

whitePaper | January 4, 2022

The Biotechnology Innovation Organization (BIO) appreciates the opportunity to participate in the 2022 Special 301 Review: Identification of Countries under Section 182 of the Trade Act of 1974: Request for Public Comment and Announcement of Public Hearing.

Read More
news image

Using Clinical Breakpoints to Improve Antimicrobial Resistance Detection

whitePaper | December 13, 2022

Define the ongoing pandemic of antimicrobial resistance. Discuss how we can address the ongoing pandemicin the Clinical Microbiology Laboratory

Read More
news image

rFC adoption for bacterial endotoxin testing

whitePaper | December 7, 2022

OVER THE LAST 20 years, the worldwide value of traded pharmaceutical goods has grown six‑fold, from $113 billion in 2000 to $629 billion in 2019.1 Yet amid such robust growth comes risk to supply chain security as manufacturers become increasingly dependent on a global network of suppliers

Read More
news image

The colors of life: an interdisciplinary artist-in-residence project to research fungal pigments as a gateway

whitePaper | January 10, 2022

Biological pigmentation is one of the most intriguing traits of many fungi. It holds signifcance to scientists, as a sign of biochemical metabolism and organism-environment interaction, and to artists, as the source of natural colors that capture the beauty of the microbial world.

Read More

Spotlight

Neem Biotech Limited

Neem Biotech is an established and now rapidly growing Wales-based biotechnology R&D company. Like Zaluvida, our parent company, we dare to dream big within our areas of expertise in the life sciences in order to pioneer health innovations that go some way to making the world a little better.

Events